Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials-Reference-Cited by-同舟云学术

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

Published:2011-05 Issue:9779 Volume:377 Page:1760-1769
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Noble Paul W,Albera Carlo,Bradford Williamson Z,Costabel Ulrich,Glassberg Marilyn K,Kardatzke David,King Talmadge E,Lancaster Lisa,Sahn Steven A,Szwarcberg Javier,Valeyre Dominique,du Bois Roland M

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement;Am J Respir Crit Care Med,2000

2. Determinants of survival in idiopathic pulmonary fibrosis;Schwartz;Am J Respir Crit Care Med,1994

3. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis;Bjoraker;Am J Respir Crit Care Med,1998

4. Predicting survival in idiopathic pulmonary fibrosis. Scoring system and survival model;King;Am J Respir Crit Care Med,2001

5. Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis;Iyer;J Pharmacol Exp Ther,1999

Cited by 1728 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Idiopathic pulmonary fibrosis with a typical usual interstitial pneumonia pattern on chest high-resolution computed tomography;Rare and Interstitial Lung Diseases;2025

2. “Bubbly lung”, a honeycombing variant with more favorable outcome;Respiratory Investigation;2024-11

3. A systematic review and meta-analysis of the clinical benefits and adverse reactions of anti-fibrotics in non-IPF progressive fibrosing ILD;Heart & Lung;2024-11

4. Early pirfenidone treatment enhances lung function in idiopathic pulmonary fibrosis patients;World Journal of Clinical Cases;2024-10-06

5. Efficacy and safety of pharmacological treatments for autoimmune disease-associated interstitial lung disease: A systematic review and network meta-analysis;Seminars in Arthritis and Rheumatism;2024-10